Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Gastroenterology. 2018 Dec;155(6):2016-2018.e11. doi: 10.1053/j.gastro.2018.09.020. Epub 2018 Sep 13.
Epithelial cells in the circulation (circulating epithelial cells, or CECs) are analyzed as a non-invasive method to detect cancers; we investigated whether analysis of hepatocytes in the circulation can identify patients with chronic liver disease or hepatocellular carcinoma (HCC). We previously developed a cell-sorting device to isolate CECs from patient blood samples and combined it with an mRNA analysis system to identify CECs with liver-specific markers. We tested the ability of this device to detect CECs of hepatocyte origin in blood samples from healthy individuals (n=10), patients with chronic liver disease without HCC (n=39), and patients with HCC (n=54), using immunofluorescence. We confirmed hepatocyte origin using RNA-sequencing analysis. We found a similar concentration of circulating hepatocytes in blood samples from patients with chronic liver disease and HCC but an increased concentration from patients with advanced fibrosis compared to those without advanced fibrosis. Circulating hepatocytes isolated from patients with HCC had a different gene expression profile than those from patients with chronic liver disease. This system for detecting and analyzing circulating hepatocytes might be used in the evaluation of benign and malignant liver disease.
循环中的上皮细胞(循环上皮细胞,或 CECs)被分析为一种非侵入性方法来检测癌症;我们研究了分析循环中的肝细胞是否可以识别慢性肝病或肝细胞癌(HCC)患者。我们之前开发了一种细胞分选装置,从患者的血液样本中分离 CECs,并将其与 mRNA 分析系统相结合,以识别具有肝脏特异性标记的 CECs。我们使用免疫荧光法测试了该装置在来自健康个体(n=10)、无 HCC 的慢性肝病患者(n=39)和 HCC 患者(n=54)的血液样本中检测源自肝细胞的 CECs 的能力。我们使用 RNA 测序分析证实了肝细胞的来源。我们发现慢性肝病和 HCC 患者的血液样本中循环肝细胞的浓度相似,但与无晚期纤维化的患者相比,晚期纤维化患者的浓度增加。从 HCC 患者中分离出的循环肝细胞的基因表达谱与慢性肝病患者不同。这种用于检测和分析循环肝细胞的系统可能用于评估良性和恶性肝病。